✦ LIBER ✦

Combination therapy with prostacyclin and tadalafil for severe pulmonary arterial hypertension: A pilot study

✍ Scribed by Daniele BENDAYAN; David SHITRIT; Mordechai R. KRAMER

Book ID: 108964745
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 45 KB
Volume: 13
Category: Article
ISSN: 1323-7799
DOI: 10.1111/j.1440-1843.2007.01176.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Timeline of haemodynamic improvement wit

Timeline of haemodynamic improvement with subcutaneous prostacyclin therapy in a patient with severe pulmonary arterial hypertension

✍ R. Sadushi-Koliçi; W. Perthold; F. M. Fruhwald; I. M. Lang 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Combination therapy with mizoribine for

Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study

✍ Norishige Yoshikawa; Koichi Nakanishi; Kenji Ishikura; Hiroshi Hataya; Kazumoto 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 148 KB

First experience with an oral combinatio

First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension

✍ K. Lunze; N. Gilbert; S. Mebus; O. Miera; W. Fehske; F. Uhlemann; E. G. Mühler; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

Feasibility study of aerosolized prostag

Feasibility study of aerosolized prostaglandin E1 microspheres as a noninvasive therapy for pulmonary arterial hypertension

✍ Vivek Gupta; Amit Rawat; Fakhrul Ahsan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

This study was designed to test the feasibility of polymeric microspheres as an inhalable carrier for prostaglandin E 1 (PGE 1 ) for treatment of pulmonary arterial hypertension. Poly(lactic-co-glycolic acid) (PLGA) microspheres were prepared by a double emulsion-solvent evaporation method. Six diff

Improvement in pulmonary hemodynamics du

Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension

✍ Michael J. Krowka; Robert P. Frantz; Michael D. McGoon; Cathy Severson; David J. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Pulmonary hypertension associated with increased pulmonary vascular resistance (PVR) and occurring in the setting of portal hypertension is referred to as ''portopulmonary hypertension.'' Intravenous epoprostenol (prostacyclin) is a potent pulmonary and systemic vasodilator with antithrombotic prope

Long-term iloprost infusion therapy for

Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases

✍ Jose De La Mata; Miguel A. Gomez-Sanchez; Mercedes Aranzana; Juan J. Gomez-Reino 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 613 KB

Objective. To determine the effects of short-term, maximum-tolerated-dose and long-term, optimum-dose iloprost treatment of severe pulmonary hypertension associated with systemic sclerosis (SSc) and the primary antiphospholipid syndrome (APS). Methods. Three patients with SSc and 2 with APS who had